Quantum Cyber Finalizes Major IP Acquisition for Cyber/Drone Pivot, Issuing 25M Shares at Deep Discount
QUCY has more than doubled off its 52-week low of $0.3.
Summary
Quantum Cyber N.V. finalized a major IP acquisition for its pivot to cyber/drones, agreeing to pay $5 million cash and issue 25 million shares at a deep discount, confirming significant dilution for existing shareholders.
Key Events · Financing and Capital Events · QUCY
-
Definitive IP License Agreement
Quantum Cyber N.V. entered into an Intellectual Property License Agreement with BP United Inc. for an exclusive, perpetual, worldwide license covering cyber and drone technology, central to its business pivot.
-
Substantial Consideration for IP
The company agreed to pay $5 million in cash and issue 20 million restricted shares to BP United Inc. for the IP license. An additional 5 million restricted shares were agreed to be issued to Alexander Gurevich for an advisory agreement.
-
Significant Dilution at Deep Discount
A total of 25 million restricted shares will be issued at a price of $0.40 per share, representing a substantial dilutive event given the current stock price of $3.44 and the company's market capitalization.
-
New Director Appointed
Peter O'Rourke, with extensive experience in government, consulting, and corporate governance, was appointed to the Board of Directors, effective May 13, 2026.
Analysis · QUCY · Life Sciences
This 8-K provides the definitive terms for the 'highly dilutive IP acquisition' and 'radical business pivot' previously disclosed in the May 15th 10-Q. The company has agreed to pay $5 million in cash and issue 20 million restricted shares for the IP license, plus an additional 5 million restricted shares for an advisory agreement. All shares are priced at $0.40, a deep discount to the current stock price of $3.44. This represents a substantial outlay of $15 million (at the transaction price) for a company with a ~$41 million market cap, confirming significant dilution for existing shareholders as part of its strategic shift into cyber and drone technology.
At the time of this filing, QUCY was trading at $3.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $41.3M. The 52-week trading range was $0.30 to $4.93. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.